Photo of Ruben Mesa from thepatientstory.com
Oct 1, 2023, 00:13
Ruben Mesa: Glad to have the opportunity to discuss the FDA approval of momelotinib for patients with myelofibrosis in this interview with Pharmacy Times!
Ruben Mesa, President at Atrium Health Levine Cancer, Executive Director at Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Vice Dean at Cancer Wake Forest School of Medicine, and SVP at Atrium Health, made the following post on LinkedIn:
“Glad to have the opportunity to discuss the FDA approval of momelotinib for patients with myelofibrosis in this interview with Pharmacy Times! Levine Cancer Institute Atrium Health Wake Forest Baptist Comprehensive Cancer Center Atrium Health Advocate Health GSK”
For details click here.
Source: Ruben Mesa/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 23, 2024, 21:21
Dec 23, 2024, 21:19
Dec 23, 2024, 21:16
Dec 23, 2024, 21:09
Dec 23, 2024, 20:37
Dec 23, 2024, 20:18
Dec 23, 2024, 20:14